Shares of Bristol Myers Squibb Co. BMY advanced 1.17% to $48.46 Monday, on what proved to be an all-around positive trading ...

Shares trade at one of the lowest earnings multiples among its peers. Most of the investment bank analysts who cover the ...

Leading health technology company MentalHealth.com is pleased to announce its acquisition of online mental health resource ...

Adding pembrolizumab (Keytruda), before and after surgery, to standard adjuvant therapy for locally advanced head and neck ...

We recently published a list of 10 Stocks to Watch as Trade Wars Begin. In this article, we are going to take a look at where ...

The addition of neoadjuvant and adjuvant pembrolizumab to standard of care significantly improved outcomes for certain ...

The UK’s Voluntary Scheme for Branded Medicines Pricing and Access ( VPAG) was agreed upon by the ABPI, the research-based ...

As an unplanned overall survival analysis of ivonescimab’s Keytruda head-to-head trial rocked the PD- (L)1xVEGF world, Akeso ...

Research shows improved survival outcomes with statin use in patients with chronic lymphocytic leukemia receiving ibrutinib treatment.

ATLANTA, GEORGIA / ACCESS Newswire / April 28, 2025 / Leading health technology company MentalHealth.com is pleased to announce its acquisition of online mental health resource and clinical guidelines ...

Neoadjuvant PD-1 blockade in dMMR tumors "could potentially eradicate the need for chemotherapy, radiation, and surgery in ...

The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies. The RSI is a ...